Back to search results

A Study of Ranolazine in ALS

Abroad (travel likely)RecruitingPHASE2

Conditions

Amyotrophic Lateral Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Michael Han) · Michael.Han@ucsf.edu · 415-353-7381
    Study coordinator · Neuromuscular.Research@ucsf.edu
    Contact: Principal Investigator (Swathy Chandrashekhar, MD)

  • Mayo Clinic Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Huy B. Tran) · Tran.Huy1@mayo.edu · 904-953-4503
    Contact: Principal Investigator (Bjorn E Oskarsson, MD)

  • University of Kansas Medical Center, Fairway, Kansas, United States

    Contact: Study coordinator (Nick Staudenmier, BS) · nstaudenmier@kumc.edu · 913-945-9922
    Contact: Study coordinator (Katie Lillig, BS) · Kjennens2@kumc.edu · 913-945-9932
    Contact: Principal Investigator (Jeffrey Statland, MD)

  • University of Kansas Medical Center: Wichita, Wichita, Kansas, United States

    Contact: Study coordinator (KUMC CTSU Wichita) · clinicaltrialunit@kumc.edu · 316-293-1833
    Contact: Study coordinator (Hannah Hancock) · hhancock@kumc.edu
    Contact: Principal Investigator (Matthew Byerly, MD)

  • University of Missouri Health Care, Columbia, Missouri, United States

    Contact: Study coordinator (Amanda Heider) · ahmc4@umsystem.edu · 573-884-6852
    Contact: Principal Investigator (William D Arnold, MD)

  • The Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (Atchayah Balakrishna) · Atchayah.Balakrishna@osumc.edu
    Contact: Study coordinator (Kaneshia Hives) · Kaneshia.Hives@osumc.edu
    Contact: Principal Investigator (Sarah Heintzman, CNP)
Study leads

  • Jeffrey Statland, MD

    Principal Investigator

    University of Kansas Medical Center

View source on ClinicalTrials.gov(opens in a new tab)